最大化新生儿筛查对庞贝病、脊髓性肌萎缩症和杜氏肌营养不良症救命治疗的益处:关键步骤
本文讨论美国新生儿筛查(NBS)流程的复杂性,重点关注神经肌肉疾病的挑战。随着新干预措施出现,临床界需克服将新疾病加入筛查面板的障碍,并理解联邦层面的严格证据审查和州级实施的复杂过程。庞贝病和脊髓性肌萎缩症的NBS项目可为杜氏肌营养不良症等未来候选疾病提供路径。
要点
- 新生儿筛查可早期识别特定先天疾病,早期干预不仅能预防终身残疾,更能挽救生命。
- 将神经肌肉疾病加入筛查面板面临流程挑战,需理解联邦证据审查和州级实施复杂性。
- 庞贝病和脊髓性肌萎缩症的筛查经验可为杜氏肌营养不良症等未来候选疾病提供指导。
核心结论
- 先进筛查方法、有效治疗的出现以及专业组织的支持可能促进新生儿筛查扩展,使更多婴儿在新生儿期被识别并从救命干预中获益。
研究设计与样本
- 本文为观察性综述,讨论美国新生儿筛查流程的复杂性,重点关注神经肌肉疾病。
主要发现
- 新生儿筛查可识别特定先天疾病婴儿,早期干预可预防终身残疾并挽救生命。
- 将新疾病加入筛查面板面临挑战,需理解联邦层面严格证据审查和州级实施复杂过程。
- 庞贝病和脊髓性肌萎缩症的新生儿筛查项目可为杜氏肌营养不良症等未来候选疾病提供路径。
临床怎么用
- 临床界应准备克服将新神经肌肉疾病加入新生儿筛查面板的挑战,并理解联邦证据审查和州级实施流程。
- 可利用庞贝病和脊髓性肌萎缩症的筛查经验指导杜氏肌营养不良症等疾病的筛查实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Newborn screening (NBS) identifies infants with specific congenital disorders for which earlier intervention cannot only prevent a lifetime of chronic disability but also, most importantly, save lives. In this article, we discuss complexities associated with NBS processes in the United States, with a focus on challenges in neuromuscular disorders. OBSERVATIONS: As new interventions for neuromuscular disorders become available, the clinical community must prepare to overcome the challenges of adding new diseases to screening panels and understand the rigorous evidence review at the federal level and the complex process of state-level implementation. In this regard, NBS programs for Pompe disease and spinal muscular atrophy can guide the path of Duchenne muscular dystrophy and other neuromuscular disorders as future candidates for NBS. CONCLUSIONS AND RELEVANCE: The availability of advanced screening methods, the emergence of effective treatment, and the support of professional organizations may facilitate the expansion of NBS, such that an increasing number of infants can be identified in the newborn period who will benefit from life-saving interventions.
引用
- Baker M, Griggs R, Byrne B, et al. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019. PMID: 31107518. doi:10.1001/jamaneurol.2019.1206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。